Chronic cavitary pulmonary histoplasmosis treated with isavuconazole after a hypersensitivity reaction to

Miguel E Cervera-Hernandez1, Sunit P Jariwala2

  • 1Infectious Diseases, Sanford University of South Dakota Medical Center, Sioux Falls, 57105, South Dakota, USA.

PubMed

Insights

Chronic cavitary pulmonary histoplasmosis treatment can be challenging due to itraconazole hypersensitivity. Isavuconazole offers a promising alternative therapy for patients experiencing adverse reactions to itraconazole.

Area of Science:

  • Mycology
  • Pulmonology
  • Infectious Diseases

Background:

  • Chronic cavitary pulmonary histoplasmosis (CCPH) necessitates long-term antifungal treatment, typically with itraconazole.
  • Hypersensitivity reactions to itraconazole, while uncommon, present a significant clinical challenge in managing CCPH.
  • Limited data exists on the efficacy and cross-reactivity of newer azole antifungals in CCPH patients with itraconazole intolerance.

Observation:

  • A patient with CCPH developed a hypersensitivity reaction to itraconazole, precluding its continued use.
  • Alternative azole antifungal therapy was considered due to the need for sustained treatment of CCPH.

Findings:

  • The patient was successfully treated with isavuconazole after experiencing an itraconazole-induced hypersensitivity reaction.
  • This case demonstrates the successful use of isavuconazole in a patient with CCPH who could not tolerate itraconazole.

Implications:

  • Isavuconazole represents a viable and effective alternative treatment option for CCPH in patients with itraconazole hypersensitivity.
  • Further research into the role of newer azoles like isavuconazole in managing complex fungal infections is warranted.
  • This case contributes to the understanding of azole cross-reactivity and treatment strategies for refractory or intolerant histoplasmosis cases.

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
207
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
987
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
399
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
246
Upper Respiratory Drugs: First and Second-Generation Antihistamines01:15

Upper Respiratory Drugs: First and Second-Generation Antihistamines

Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
467
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
332